Advertisement
Advertisement
ARAY
Accuray Incorporated
0.55
USDSponsored
+0.01
+2.11%
Feb 13, 15:59 UTC -5
Closed
After-Market
0.58
+0.03
+5.11%
ARAY Earnings Reports
Positive Surprise Ratio
ARAY beat 24 of 40 last estimates.
60%
Next Report
Date of Next Report
Apr 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$114.14M
/-$0.05
Implied change from Q2 26 (Revenue/ EPS)
+11.64%
/-54.55%
Implied change from Q3 25 (Revenue/ EPS)
+0.79%
/+400.00%
Accuray Incorporated earnings per share and revenue
On Feb 04, 2026, ARAY reported earnings of -0.11 USD per share (EPS) for Q2 26, beating the estimate of -0.11 USD, resulting in a 1.96% surprise. Revenue reached 102.24 million, compared to an expected 102.87 million, with a -0.61% difference. The market reacted with a -20.68% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 114.14 million USD, implying an decrease of -54.55% EPS, and increase of 11.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Artivion, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
$0.08
Actual
$0.17
Surprise
+104.08%
iRadimed Corporation
Report Date
Feb 10, 2026 For Q4 25
Estimate
$0.48
Actual
$0.54
Surprise
+10.29%
Pacific Biosciences of California, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.12
Surprise
+20.27%
Electromed, Inc.
Report Date
Feb 10, 2026 For Q2 26
Estimate
$0.27
Actual
$0.32
Surprise
+17.22%
CVRx, Inc. Common Stock
Report Date
Feb 12, 2026 For Q4 25
Estimate
-$0.44
Actual
-$0.46
Surprise
-3.09%
Sensus Healthcare, Inc
Report Date
Feb 12, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.19
Surprise
-166.11%
Edwards Lifesciences Corp
Report Date
Feb 10, 2026 For Q4 25
Estimate
$0.63
Actual
$0.57
Surprise
-8.85%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
DexCom, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
$0.66
Actual
$0.68
Surprise
+2.56%
FAQ
What were Accuray Incorporated's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Accuray Incorporated reported EPS of -$0.11, beating estimates by 1.96%, and revenue of $102.24M, -0.61% below expectations.
How did the market react to Accuray Incorporated's Q2 2026 earnings?
The stock price moved down -20.68%, changed from $0.76 before the earnings release to $0.60 the day after.
When is Accuray Incorporated expected to report next?
The next earning report is scheduled for Apr 28, 2026.
What are the forecasts for Accuray Incorporated's next earnings report?
Based on 4
analysts, Accuray Incorporated is expected to report EPS of -$0.05 and revenue of $114.14M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement